AFT not ready to take its medicine for ‘misleading’ Maxigesic ads
Appeals 2019-02-08 10:54 pm By Cat Fredenburgh | Melbourne
Please login to bookmark Close

AFT Pharmaceuticals has launched a partial challenge to a court ruling that its Maxigesic ads made a number of misleading claims, including that the drug provides stronger and more effective relief than Reckitt Benckiser’s Nuromol.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au